Fluorocarbon nanoparticles as multifunctional drug delivery vehicles

References

• Ahrens ET, Flores R, Xu H, Morel PA. In vivo imaging platform for tracking immunotherapeutic cells. Nat Biotech 2005; 23(8)983–987
   PubMed Web of Science ®Google Scholar
• Al-Hallaq HA, Zamora M, Fish BL, Farrell A, Moulder JE, Karczmar GS. MRI measurements correctly predict the relative effects of tumor oxygenation agents on hypoxic fraction in rodent BA1112 tumors. Int J Radiat Oncol Biol Phys 2000; 47: 481–488
   PubMed Web of Science ®Google Scholar
• Anderson SA, Rader RK, Westlin WF, Null C, Jackson D, Lanza GM, Wickline SA, Kotyk JJ. Magnetic resonance contrast enhancement of neovasculature with αvβ3-targeted nanoparticles. Magn Reson Med 2000; 44: 433–439
   PubMed Web of Science ®Google Scholar
• Berkowitz BA, Handa JT, Wilson CA. Perfluorocarbon temperature measurements using 19F NMR. NMR Biomed 1992; 5: 65–68
   PubMed Web of Science ®Google Scholar
• Boerman OC, van Schaijk FG, Oyen WJG, Corstens FHM. Pretargeted radioimmunotherapy of cancer: Progress step by step. J Nucl Med 2003; 44: 400–411
   PubMed Web of Science ®Google Scholar
• Brix G, Bellemann ME, Haberkorn U, Gerlach L, Lorenz WJ. Assessment of the biodistribution and metabolism of 5-fluorouracil as monitored by 18F PET and 19F MRI: A comparative animal study. Nucl Med Biol 1996; 23: 897–906
   PubMed Web of Science ®Google Scholar
• Brix G, Schlicker A, Mier W, Peschke P, Bellemann ME. Biodistribution and pharmacokinetics of the 19F-labeled radiosensitizer 3-aminobenzamide: Assessment by 19F MR imaging. Magn Reson Imag 2005; 23: 967–976
   PubMed Web of Science ®Google Scholar
• Bushnell D, O'Dorisio T, Menda Y, Carlisle T, Zehr P, Connolly M, Karwal M, Miller S, Parker S, Bouterfa H. Evaluating the clinical effectiveness of 90Y-SMT 487 in patients with neuroendocrine tumors. J Nucl Med 2003; 44: 1556–1560
   PubMed Web of Science ®Google Scholar
• Canera L, Kinuya S, Garmestani K, Brechbiel MW, Wu C, Pai LH, McMurry TJ, Gansow OA, Pastan I, Paik CH, Carrasquillo JA. Comparative biodistribution of indium- and yttrium-labeled B3 monoclonal antibody conjugated to either 2-(p-SCN-Bz)-6-methyl-DTPA (1B4M-DTPA) or 2-(p-SCN-Bz)-1,4,7,10-tetraazacyclododecane tetraacetic acid (2B-DOTA). Eur J Nucl Med 1994; 21: 640–646
   PubMedGoogle Scholar
• Carrasquillo JA, White JD, Paik CH, Raubitschek A, Le N, Rotman M, Brechbiel MW, Gansow OA, Top LE, Perentesis P, Reynolds JC, Nelson DL, Waldman TA. Similarities and differences in 111In and 90Y-labeled antiTac monoclonal antibody distribution. J Nucl Med 1999; 40: 268–276
   PubMed Web of Science ®Google Scholar
• Chandler D. Structures of molecular liquids. Annu Rev Phys Chem 1978; 29: 441–471
   Web of Science ®Google Scholar
• Curran D, Lee Z. Fluorous techniques for the synthesis and separation of organic molecules. Green Chem 2001; G3–G7
   Google Scholar
• Fan X, River JN, Zamora M, Al-Hallaq HA, Karczmar GS. Effect of carbogen on tumor oxygenation: Combined fluorine-19 and proton MRI measurements. Int J Radiat Oncol Biol Phys 2002; 54: 1202–1209
   PubMed Web of Science ®Google Scholar
• Flacke S, Fischer S, Scott MJ, Fuhrhop RJ, Allen JS, McLean M, Winter P, Sicard GA, Gaffney PJ, Wickline SA, Lanza GM. Novel MRI contrast agent for molecular imaging of fibrin. Circulation 2001; 104: 1280–1285
   PubMed Web of Science ®Google Scholar
• Fyles AW, Milosevic M, Wong R, Kavanagh M-C, Pintilie M, Sun A, Chapman W, Levin W, Manchul L, Keane TJ, Hill RP. Oxygenation predicts radiation response and survival in patients with cervix cancer. Radiother Oncol 1998; 48: 149–156
   PubMed Web of Science ®Google Scholar
• Goldenberg DM. Targeted therapy of cancer with radiolabeled antibodies. J Nucl Med 2002; 43: 693–713
   PubMed Web of Science ®Google Scholar
• Hamblett KJ, Kegley BB, Hamlin DK, Chyan MK, Hyre DE, Press OW, Wilbur DS, Stayton PS. A streptavidin–biotin system that minimizes blocking by endogenous biotin. Bioconjug Chem 2002; 13: 588–598
   PubMed Web of Science ®Google Scholar
• Huang MQ, Basse PH, Yang Q, Horner JA, Hichens TK, Ho C. MRI detection of tumor in mouse lung using partial liquid ventilation with a perfluorocarbon-in-water emulsion. Magn Reson Imag 2004; 22: 645–652
   PubMed Web of Science ®Google Scholar
• Hunjan S, Mason RP, Constantinescu A, Peschke P, Hahn EW, Antich PP. Regional tumor oximetry: 19F NMR spectroscopy of hexafluorobenzene. Int J Radiat Oncol Biol Phys 1998; 41: 161–171
   PubMed Web of Science ®Google Scholar
• Kimura A, Narazaki M, Kanazawa Y, Fujiwara H. 19F magnetic resonance imaging of perfluorooctanoic acid encapsulated in liposome for biodistribution measurement. Magn Reson Imag 2004; 22: 855–860
   PubMed Web of Science ®Google Scholar
• Klibanov AL. Ligand-carrying gas-filled microbubbles: Ultrasound contrast agents for targeted molecular imaging. Bioconjug Chem 2005; 16: 9–17
   PubMed Web of Science ®Google Scholar
• Knox SJ, Goris ML, Tempero M, Weiden PL, Gentner L, Breitz H, Adams GP, Axworthy D, Gaffigan S, Bryan K, Fisher DR, Colcher D, Horak ID, Weiner LM. Phase II trial of yttrium-90-DOTA pretargeted by NR-LU-10 antibody/streptavidin in patients with metastatic colon cancer. Clin Cancer Res 2000; 6: 406–414
   PubMed Web of Science ®Google Scholar
• Koch CJ, Oprysko PR, Shuman AL, Jenkins WT, Brandt G, Evans SM. Radiosensitization of hypoxic tumor cells by dodecafluoropentane: A gas-phase perfluorocarbon emulsion. Cancer Res 2002; 62: 3626–3629
   PubMed Web of Science ®Google Scholar
• Koziara JM, Lockman PR, Allen DD, Mumper RJ. In situ blood–brain barrier transport of nanoparticles. Pharm Res 2003; 20: 1772–1778
   PubMed Web of Science ®Google Scholar
• Kreuter J. Nanoparticle systems for brain delivery of drugs. Adv Drug Del Rev 2001; 47: 65–81
   PubMed Web of Science ®Google Scholar
• Lanza GM, Wickline SA. Targeted ultrasonic contrast agents for molecular imaging and therapy. Prog Cardiovasc Dis 2001; 44: 13–31
   PubMed Web of Science ®Google Scholar
• Lanza GM, Wallace KD, Scott MJ, Cacheris WP, Abendschein DR, Christy DH, Sharkey AM, Miller JG, Gaffney PJ, Wickline SA. A novel site-targeted ultraosonic contrast agent with broad biomedical application. Circulation 1996; 94: 3334–3340
   PubMed Web of Science ®Google Scholar
• Lanza GM, Abendschein DR, Hall CS, Marsh JN, Scott MJ, Scherrer DE, Wickline SA. Molecular imaging of stretch-induced tissue factor expression in carotid arteries with intravascular ultrasound. Invest Radiol 2000; 35: 227–234
   PubMed Web of Science ®Google Scholar
• Lanza GM, Yu X, Winter PM, Abendschein DR, Karukstis KK, Scott MJ, Chinen LK, Fuhrhop RW, Scherrer DE, Wickline SA. Targeted antiproliferative drug delivery to vascular smooth muscle cells with a magnetic resonance imaging nanoparticle contrast agent. Circulation 2002; 106: 2842–2847
   PubMed Web of Science ®Google Scholar
• Liu S, Pietryka J, Ellars CE, Edwards DS. Comparison of yttrium and indium complexes of DOTA–BA and DOTA–MBA: Models for 90Y- and 111In-labeled DOTA-biomolecule conjugates. Bioconjug Chem 2002; 13: 902–913
   PubMed Web of Science ®Google Scholar
• Longmaid HE, Adams DF, Neirinckx RD, Harrison CG, Brunner P, Seltzer SE, Davis MA, Neuringer L, Geyer RP. In vivo19F NMR imaging of liver, tumor, and abscess in rats. Invest Radiol 1985; 20: 141–145
   PubMed Web of Science ®Google Scholar
• Lővqvist A, Humn JL, Sheikh A, Finn RD, Koziorowski J, Ruan S, Pentlow KS, Jungbluth A, Welt S, Lee FT, Brechbiel MW, Larson SM. PET imaging of 86Y-labeled anti Lewis Y monoclonal antibodies in a nude mouse model: Comparison between 86Y and 111In radiolabels. J Nucl Med 2001; 42: 1281–1287
   PubMed Web of Science ®Google Scholar
• Mason RP, Antich PP, Babcock EE, Gerberich JL, Nunnally RL. Perfluorocarbon imaging in vivo: A 19F MRI study in tumor-bearing mice. Magn Reson Imag 1989; 7: 475–485
   PubMed Web of Science ®Google Scholar
• Mason RP, Shukla H, Antich PP. In vivo oxygen tension and temperature: Simultaneous determination using 19F NMR spectroscopy of perfluorocarbon. Magn Reson Med 1993; 29: 296–302
   PubMed Web of Science ®Google Scholar
• Mason RP, Hunjan S, Le D, Constaninescu A, Barker BR, Wong PS, Peschke P, Hahn EW, Antich PP. Regional tumor oxygen tension: Fluorine echo planar imaging of hexafluorobenzene reveals heterogeneity of dynamics. Int J Radiat Oncol Biol Phys 1998; 42: 747–750
   PubMed Web of Science ®Google Scholar
• McIntyre DJO, McCoy CL, Griffiths JR. Tumour oxygenation measurements by 19F magnetic resonance imaging of perfluorocarbons. Curr Sci 1999; 76: 753–761
   Web of Science ®Google Scholar
• Meyer KL, Carvlin MJ, Mukherji B, Sloviter HA, Joseph PM. Fluorinated blood substitute retention in the rat measured by fluorine-19 magnetic resonance imaging. Invest Radiol 1992; 27: 620–627
   PubMed Web of Science ®Google Scholar
• Mishima H, Kobayashi T, Shimizu M, Tamaki Y, Baba M, Shimano T, Itoh S, Yamazaki M, Iriguchi N, Takahashi M, Takesada M. In vivo F-19 shift imaging with FTPA and antibody-coupled FMIQ. J Magn Reson Imag 1991; 1: 705–709
   PubMed Web of Science ®Google Scholar
• Morawski AM, Winter PM, Crowder KC, Caruthers SD, Fuhrhop RW, Scott MJ, Robertson JD, Abendschein DR, Lanza GM, Wickline SA. Targeted nanoparticles for quantitative imaging of spare molecular epitopes with MRI. Magn Reson Med 2004a; 51: 480–486
   PubMed Web of Science ®Google Scholar
• Morawski AM, Winter PM, Yu X, Fuhrhop RW, Scott MJ, Hockett F, Robertson JD, Gaffney PJ, Lanza GM, Wickline SA. Quantitative “magnetic resonance immunohistochemistry” with ligand-targeted 19F nanoparticles. Magn Reson Med 2004b; 52: 1255–1262
   PubMed Web of Science ®Google Scholar
• Niiler E. Setbacks for blood substitute companies. Nat Biotech 2002; 209: 62–963
   Google Scholar
• Nordsmark M, Overgaard J. A confirmatory prognostic study on oxygenation status and loco-regional control in advanced head and neck squamous cell carcinoma treated by radiation therapy. Radiother Oncol 2000; 57: 39–43
   PubMed Web of Science ®Google Scholar
• O'Hara JA, Goda F, Demidenko E, Swartz HM. Effect on regrowth delay in a murine tumor of scheduling spit dose radiation based on direct pO2 measurements by EPR oximetry. Radiat Res 1998; 150: 549–556
   PubMed Web of Science ®Google Scholar
• O'Hara JA, Blumenthal RD, Grinberg OY, Demidenko E, Grinberg S, Wilmot CM, Taylor AM, Goldenberg DM, Swartz HM. Response to radioimmunotherapy correlates with tumor pO2 measured by EPR oximetry in human tumor xenografts. Radiat Res 2001; 155: 466–473
   PubMed Web of Science ®Google Scholar
• Otte A, Herrmann R, Heppeler A, Behe M, Jermann E, Powell P, Maecke HR, Muller J. Yttrium-90 DOTATOC: First clinical results. Eur J Nucl Med 1999; 26: 1439–1447
   PubMedGoogle Scholar
• Paganelli G, Zoboli S, Cremonesi M, Bodei L, Ferrari M, Grana C, Bartolomei M, Orsi F, de Cicco C, Macke HR, Chinol M, de Braud D. Receptor-mediated radiotherapy with 90Y-DOTA-D-Phe1-Tyr3-octreotide. Eur J Nucl Med 2001; 28: 426–434
   PubMedGoogle Scholar
• Parhaml P, Fung BM. Fluorine-19 relaxation study of perfluoro chemicals as oxygen carriers. J Phys Chem 1983; 87: 1928–1931
   Web of Science ®Google Scholar
• Postel M, Riess JG, Weers JG. Fluorocarbon emulsions—the stability issue. Artif Cells Blood Substit Immobil Biotechnol 1994; 22: 991–1005
   PubMed Web of Science ®Google Scholar
• Ratner AV, Muller HH, Bradley-Simpson B, Johnson DE, Hurd RE, Sotak C, Young SW. Detection of tumors with 19F magnetic resonance imaging. Invest Radiol 1988; 23: 361–364
   PubMed Web of Science ®Google Scholar
• Riess JG. Oxygen carriers (“blood substitutes”)—raison d'etre, chemistry and some physiology. Chem Rev 2001; 101: 2797–2919
   PubMed Web of Science ®Google Scholar
• Riess JG. Understanding the fundamentals of perfluorocarbons and perfluorocarbon emulsions relevant to in vivo oxygen delivery. Artif Cells Blood Substit Biotechnol 2005; 33: 47–63
   PubMed Web of Science ®Google Scholar
• Robinson SP, Griffiths JR. Current issues in the utility of 19F nuclear magnetic resonance methodologies for the assessment of tumor hypoxia. Phil Trans R Soc Lond B 2004; 359: 987–996
   PubMed Web of Science ®Google Scholar
• Rockwell S. Use of a perfluorochemical emulsion to improve oxygenation in a solid tumor. Int J Radiat Oncol Biol Phys 1985; 11: 97–103
   PubMed Web of Science ®Google Scholar
• Rose C, Lustig R, McIntosh N, Teicher B. A clinical trial of Fluosol DA 20% in advanced cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 1986; 12: 1325–1327
   PubMed Web of Science ®Google Scholar
• Schlemmer HP, Becker M, Bachert P, Dietz A, Rudat V, Vanselow B, Wollensack P, Zuna I, Knopp MV, Weidauer H, Wannenmacher M, van Kaick G. Alterations of intratumoral pharmacokinetics of 5-fluorouracil in head and neck carcinoma during simultaneous radiochemotherapy. Cancer Res 1999; 59: 2363–2369
   PubMed Web of Science ®Google Scholar
• Schmieder AH, Winter PM, Caruthers SD, Harris TD, Williams TA, Allen JS, Lacy EK, Zhang H, Scott MJ, Hu G, Robertson JD, Mickline SA, Lanza GM. Molecular MR imaging of melanoma angiogenesis with αvβ3-targeted paramagnetic nanoparticles. Magn Reson Med 2005; 53: 621–627
   PubMed Web of Science ®Google Scholar
• Shimizu M, Kobayashi T, Morimoto H, Matsuura N, Shimano T, Nomura N, Itoh S, Yamazaki M, Iriguchi N, Yamamoto T, Yamai S, Furuta T, Maki T, Mori T. Tumor imaging with anti-CEA antibody labeled 19F emulsion. Magn Reson Med 1987; 5: 290–295
   PubMed Web of Science ®Google Scholar
• Shukla HP, Mason RP, Woessner DE, Antich PP. A comparison of three commercial perfluorocarbon emulsions as high-field 19F NMR probes of oxygen tension and temperature. J Magn Reson Ser B 1995; 106: 131–141
   Google Scholar
• Tarara TE, Malinoff SH, Pelura TJ. Oxidative assessment of phospholipid-stabilized perfluorocarbon-based blood substitutes. Artif Cells Blood Substit Immobil Biotechnol 1994; 22: 1287–1293
   PubMed Web of Science ®Google Scholar
• Teicher BA, Rose CM. Perfluorochemical emulsions can increase tumor radiosensitivity. Science 1984a; 223: 934–936
   PubMed Web of Science ®Google Scholar
• Teicher BA, Rose CM. Oxygen-carrying perfluorochemical emulsion as an adjuvant to radiation therapy in mice. Cancer Res 1984b; 44: 4285–4288
   PubMed Web of Science ®Google Scholar
• Thomas C, Riess J, Guichard M. Influence of the 100% w/v perfluorooctyl bromide (PFOB) emulsion dose on tumor radiosensitivity. Int J Radiat Biol 1991; 59(2)433–445
   PubMed Web of Science ®Google Scholar
• Thomas CD, Prade M, Guichard M. Tumour oxygenation, radiosensitivity, and necrosis before and/or adfter nicotiamide, carbogen and perflubron emulsion administration. Int J Radiat Biol 1995; 67(5)597–605
   PubMed Web of Science ®Google Scholar
• van der Sanden BPJ, Heerschap A, Simonetti AW, Rijken PFJW, Peters HPW, Stuben G, van der Kogel AJ. Characterization and validation of non-invasive oxygen tension measurements in human glioma xenografts by 19F-MR relaxometry. Int J Radiat Oncol Biol Phys 1999a; 44: 649–658
   PubMed Web of Science ®Google Scholar
• van der Sanden BPJ, Heerschap A, Hoofd L, Simonetti AW, Nicolay K, van der Toorn A, Colier WNJM, van der Kodel AJ. Effect of carbogen breathing on ths physiological profile of human glioma xenografts. Magn Reson Imag 1999b; 42: 490–499
   Web of Science ®Google Scholar
• Wahl RL. Tositumomab and 131I therapy in non-Hodgkin's lymphoma. J Nucl Med 2005; 46(Suppl. 1)128S–140S
   PubMed Web of Science ®Google Scholar
• Winter PM, Caruthers SD, Kassner A, Harris TD, Chinen LK, Allen JS, Lacy EK, Zhang H, Robertson JD, Wickline SA, Lanza GM. Molecular imaging of angiogenesis in nascent Vx-2 rabbit tumor using a novel αvβ3-targeted nanoparticle and 1.5 tesla magnetic resonance imaging. Cancer Res 2003a; 63: 5838–5843
   PubMed Web of Science ®Google Scholar
• Winter PM, Caruthers SD, Yu X, Song S-K, Chen J, Miller B, Bulte JWM, Robertson JD, Gaffney PJ, Wickline SM, Lanza GM. Improved molecular imaging contrast agent for detection of human thrombus. Magn Reson Med 2003b; 50: 411–416
   PubMed Web of Science ®Google Scholar
• Zhao D, Constantinescu A, Jiang L, Hahn EW, Mason RP. Prognostic radiology: Quantitative assessment of tumor oxygen dynamics by MRI. Am J Clin Oncol 2001; 24: 462–466
   PubMed Web of Science ®Google Scholar
• Zhao D, Jiang L, Mason RP. Measuring changes in tumor oxygenation. Methods Enzymol 2004; 386: 378–418
   PubMed Web of Science ®Google Scholar